NUTCRACKER THERAPEUTICS INC has a total of 11 patent applications. Its first patent ever was published in 2019. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and chemical engineering are ANCORA PHARMACEUTICALS INC, PENCE INC and HIPEP LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Chemical engineering | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Analysing materials | |
#5 | Fermentation | |
#6 | Therapeutic chemical compounds | |
#7 | Microbiology | |
#8 | Chemical or physical laboratory devices | |
#9 | Chemical or physical processes |
# | Name | Total Patents |
---|---|---|
#1 | Mckinlay Colin James | 6 |
#2 | Eldridge Benjamin | 4 |
#3 | Wen Ximiao | 4 |
#4 | Mckinlay Colin | 3 |
#5 | Khandros Igor | 2 |
#6 | Deutsch Samuel | 2 |
#7 | Nath Sangeeta | 2 |
#8 | Evans Robert | 2 |
Publication | Filing date | Title |
---|---|---|
US2021039106A1 | Microfluidic apparatus and methods of use thereof | |
WO2021030218A1 | Lipidated cationic peptide-peg compositions for nucleic acid delivery | |
AU2019351268A1 | Tertiary amino lipidated cationic peptides for nucleic acid delivery |